Voyager Therapeutics Inc (VYGR) — Capital Reinvestment Ratio
Voyager Therapeutics Inc (VYGR) has a Capital Reinvestment Ratio of 0.04x as of March 2024, meaning it reinvests 0% of its operating cash flow ($58.77 Million) in capital expenditures ($2.14 Million). Check VYGR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Voyager Therapeutics Inc Capital Reinvestment Ratio (2015–2023)
This chart tracks Voyager Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Voyager Therapeutics Inc.
Annual Capital Reinvestment Ratio for Voyager Therapeutics Inc (2015–2023)
Year-by-year Capital Reinvestment Ratio for Voyager Therapeutics Inc from 2015 to 2023. See Voyager Therapeutics Inc (VYGR) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | $77.92 Million | $3.26 Million | ▼ -73.7% |
| 2019 | 0.16x | $48.67 Million | $7.72 Million | ▲ +535.9% |
| 2015 | 0.02x | $41.30 Million | $1.03 Million | — |